NK Cell Metabolism and Tumor Microenvironment

Iñigo Terrén1, Ane Orrantia1, Joana Vitallé1

  • 1Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Frontiers in Immunology
|October 17, 2019
PubMed

Insights

The tumor microenvironment (TME) hinders natural killer (NK) cell cancer immunotherapy by impairing their metabolism. Targeting this metabolic restriction is key to improving NK cell efficacy against solid tumors.

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Research

Background:

  • Natural Killer (NK) cells are crucial for cancer immunotherapy due to their innate ability to eliminate tumor cells.
  • Their effectiveness against solid tumors is limited by the immunosuppressive tumor microenvironment (TME).
  • The TME negatively impacts NK cell activation and function.

Purpose of the Study:

  • To review the effects of the TME on NK cell metabolism.
  • To explore how metabolic impairment influences NK cell effector functions.
  • To identify potential therapeutic targets within NK cell metabolism for solid tumor treatment.

Main Methods:

  • Literature review focusing on NK cell biology and the tumor microenvironment.
  • Analysis of studies investigating metabolic alterations in NK cells within the TME.
  • Synthesis of current knowledge on NK cell metabolism and effector functions.

Main Results:

  • The TME creates an unfavorable metabolic landscape for NK cells, characterized by nutrient/oxygen deprivation and high lactate levels.
  • This metabolic restriction significantly impairs NK cell effector functions, limiting their anti-tumor activity.
  • Specific metabolic pathways within NK cells are identified as being particularly affected by the TME.

Conclusions:

  • The metabolic dysfunction of NK cells in the TME is a critical barrier to successful cancer immunotherapy.
  • Targeting NK cell metabolism presents a promising strategy to enhance the efficacy of NK cell-based therapies against solid tumors.
  • Further research into modulating NK cell metabolism within the TME is warranted.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K